Your browser doesn't support javascript.
loading
Protease inhibitor Camostat Mesyalte blocks wild type SARS-CoV-2 and D614G viral entry in human engineered miniature lungs.
Wu, Tong; Rabi, Seyed A; Michaud, William A; Becerra, David; Gilpin, Sarah E; Mino-Kenudson, Mari; Ott, Harald C.
  • Wu T; Massachusetts General Hospital, Center for Regenerative Medicine, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Rabi SA; Massachusetts General Hospital, Department of Surgery, Boston, MA, USA; Massachusetts General Hospital, Division of Cardiovascular Surgery, Boston, MA, USA.
  • Michaud WA; Massachusetts General Hospital, Department of Surgery, Boston, MA, USA; Massachusetts General Hospital, Division of Surgical Oncology, Boston, MA, USA.
  • Becerra D; Duke University Medical Center, Department of General Surgery, USA.
  • Gilpin SE; Massachusetts General Hospital, Center for Regenerative Medicine, Boston, MA, USA.
  • Mino-Kenudson M; Massachusetts General Hospital, Center for Regenerative Medicine, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Massachusetts General Hospital, Department of Pathology, Boston, MA, USA.
  • Ott HC; Massachusetts General Hospital, Center for Regenerative Medicine, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Massachusetts General Hospital, Department of Surgery, Boston, MA, USA. Electronic address: hott@mgh.harvard.edu.
Biomaterials ; 285: 121509, 2022 06.
Article en En | MEDLINE | ID: mdl-35533440
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article